The International Market Analysis Research and Consulting Group (IMARC Group) has been keeping the top position in terms of provision consultancy services on management strategy and market for above 5 years.
IMARC Group serves customers from diverse industry areas in various regions of the globe by identifying their premium-value biz opps, dealing with their most burning issues, and converting their businesses. The company bears its clients a hand in improving decision-making and strategy-planning processes as well as in moving their business to a higher level.
The reports published by IMARC offer precise information on a slew of industries such as pharmaceutical, high-technology, advanced materials, food and beverage, biotechnology, nanotechnology, tourism and travel and a far more. The reports include detailed market analyses, overviews and forecasts, reviews of the economic and technological developments, profiles of the dominant companies, market/product assessments, etc. IMARC’s research approach unites deep insight into the market dynamics together with strong cooperation with each level of the client organization.
Publications found:
9,055
Sort by:
Glomerulonephritis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034
US$ 6,499.00
The 7 major glomerulonephritis markets reached a value of US$ 748.1 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 1,105.0 Million by 2034, exhibiting a growth rate (CAGR)...
May 2024
140 pages
Head and Neck Cancer Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034
US$ 6,499.00
The 7 major head and neck cancer markets reached a value of US$ 3,252.3 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 7,279.8 Million by 2034, exhibiting a growth rate (CA...
May 2024
134 pages
Heart Failure Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034
US$ 6,499.00
The heart failure market reached a value of US$ 6.6 Billion across the top 7 markets (US, EU4, UK, and Japan) in 2023. Looking forward, IMARC Group expects the top 7 markets to reach US$ 18.5 Billion...
May 2024
133 pages
Helicobacter Pylori Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034
US$ 6,499.00
The 7 major helicobacter pylori markets reached a value of US$ 3,480.9 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 3,891.7 Million by 2034, exhibiting a growth rate (CAG...
May 2024
129 pages
Hemiplegia Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034
US$ 6,499.00
The 7 major hemiplegia markets reached a value of US$ 710 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 1,040 Million by 2034, exhibiting a growth rate (CAGR) of 3.57% dur...
May 2024
130 pages
Hemophilia A Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034
US$ 6,499.00
The 7 major hemophilia A markets reached a value of US$ 10,288.7 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 28,447.2 Million by 2034, exhibiting a growth rate (CAGR) of...
May 2024
131 pages
Hemorrhoids Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034
US$ 6,499.00
The hemorrhoids market has been comprehensively analyzed in IMARC's new report titled 'Hemorrhoids Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034'. Hem...
May 2024
137 pages
Hepatic Cirrhosis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034
US$ 6,499.00
The hepatic cirrhosis market has been comprehensively analyzed in IMARC's new report titled 'Hepatic Cirrhosis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 202...
May 2024
137 pages
Hepatitis A Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034
US$ 6,499.00
The hepatitis A market reached a value of US$ 588.6 Million across the top 7 markets (US, EU4, UK, and Japan) in 2023. Looking forward, IMARC Group expects the top 7 markets to reach US$ 760.2 Million...
May 2024
135 pages
Hepatitis B Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034
US$ 6,499.00
The hepatitis B market reached a value of US$ 3.3 Billion across the top 7 markets (US, EU4, UK, and Japan) in 2023. Looking forward, IMARC Group expects the top 7 markets to reach US$ 4.9 Billion by...
May 2024
134 pages
Hepatocellular Carcinoma Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034
US$ 6,499.00
The 7 major hepatocellular carcinoma markets reached a value of US$ 780 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 1,520 Million by 2034, exhibiting a growth rate (CAGR...
May 2024
138 pages
